Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effectiveness, Feasibility and Acceptability of Seasonal Malaria Chemoprevention in Aweil South County in Northern Bahr Eel Ghazal, South Sudan: A Type 2 Hybrid Effectiveness-implementation Study Using a Convergent Mixed-methods Approach

NCT05471544 is registered in ClinicalTrials.gov with Malaria Consortium as lead sponsor.

NCT NCT05471544
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05471544 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effectiveness, Feasibility and Acceptability of Seasonal Malaria Chemoprevention in Aweil South County in Northern Bahr Eel Ghazal, South Sudan: A Type 2 Hybrid Effectiveness-implementation Study Using a Convergent Mixed-methods Approach
Lead sponsor
Malaria Consortium
Phase
Phase 3
Overall status
Unknown status
Start date
July 18, 2022
Completion date
December 31, 2024
Enrollment
3,575 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

malaria